InsidersTradesSigma
Explore the complete record of transactions filed by Kelly Patrick F., Directeur Médical. Director active across 1 companies, notably Forma Therapeutics Holdings, Inc.. Aggregated, 3 reports have been published. Total volume traded: €45k. The latest transaction was filed on 8 April 2022 (Levée d'options). Regulator: SEC (Form 4). All data is free.
3 of 3 declarations
Patrick F. Kelly is the Chief Medical Officer and Senior Vice President at Forma Therapeutics Holdings, Inc. He is responsible for the medical strategy and direction of the company’s clinical initiatives. With a strong background in the pharmaceutical sector, Mr. Kelly plays a key role in developing innovative treatments. Forma Therapeutics focuses on discovering and developing therapies for serious diseases, and his expertise is essential for the company’s growth.